UBS set CHF 255 target for Tecan stock as Buy rating holds
Published on 10/08/2026 at 17:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- UBS analyst Sebastian Vogel maintained a Buy rating and set a CHF 255.00 target for Tecan on September 28, 2026.
- Tecan reported first-half 2026 sales growth of 3.40 percent in local currencies and an adjusted EBITDA margin of 15.10 percent.
- The stock was trading at EUR 244.90 at Lang & Schwarz on October 8, 2026 at 5:08 p.m. CEST.
- Tecan is scheduled to publish its third-quarter 2026 update on November 5, 2026.
UBS analyst Sebastian Vogel maintained a Buy rating and set a CHF 255.00 price target for Tecan on September 28, 2026, as Markets Insider reported. Tecan stock was trading at EUR 244.90 at Lang & Schwarz on October 8, 2026 at 5:08 p.m. CEST, giving investors a current euro-denominated reference alongside the Swiss-franc target.
Three milestones shaped the year
On April 15, 2026, Tecan shareholders approved a stable dividend of CHF 3.00 per share, according to Borse Online. The payout provides a concrete income marker while the company works through a period of weaker profitability.
On August 11, 2026, Tecan reported first-half sales growth of 3.40 percent in local currencies and an adjusted EBITDA margin of 15.10 percent in its investor materials. The company also confirmed its 2026 outlook, as stated on its Tecan investor overview.
On September 28, 2026, UBS set the CHF 255.00 target while retaining its Buy rating. That target sits alongside a broader range of analyst views, making margin delivery and the pace of profitable growth the central valuation questions.
What does CHF 255 mean for valuation?
The target is denominated in Swiss francs, while the reference quotation in this article is in euros at Lang & Schwarz. The currencies therefore remain separate rather than forming an artificial percentage comparison.
Tecan operates in laboratory automation, supplying instruments, consumables, software and components to life-science and diagnostic customers. Its 2025 sales were CHF 883.00 million, according to a company release distributed through GlobeNewswire, while the first-half 2026 margin figure shows the operating benchmark management must defend.
Next reporting date is November 5
Tecan's calendar lists a qualitative third-quarter 2026 update for November 5, 2026. That date is the next scheduled company event and gives the market a defined checkpoint for sales trends, order entry and the confirmed full-year outlook.
Euro quote remains the reference
Tecan stock was trading at EUR 244.90 at Lang & Schwarz on October 8, 2026 at 5:08 p.m. CEST. On the SIX Swiss Exchange, the stock was last at CHF 227.60 on October 8, 2026 at 4:58 p.m. CEST, while its 52-week range was CHF 110.60 to CHF 256.80.
The further course of trading is shown by the continuously updated real-time quote of Tecan stock.
Tecan stock facts
- Company: Tecan Group AG
- ISIN: CH0012100191
- Ticker: TECN
- Primary exchange: SIX Swiss Exchange
- Price Lang & Schwarz as of October 8, 2026, 5:08 p.m. CEST: EUR 244.90
- Market capitalization: CHF 2.9 billion as of October 8, 2026
- 52-week range: CHF 110.60-256.80 as of October 8, 2026
- Sector / Industry: Healthcare / Medical Instruments and Supplies
- Index membership: SMI
- Next earnings date: November 5, 2026
Market context: Market report SMI.
